Log in to save to my catalogue

The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients

The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_89acb00832294f2f83c2f0f33e283964

The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients

About this item

Full title

The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2024-06, Vol.24 (1), p.712-10, Article 712

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Female gynecological cancers represent a serious public health problem, with 1,398,601 new diagnoses and 671,875 deaths per year worldwide. Antipsychotics are often used in psychiatric disorders, including schizophrenia, bipolar disorder, and major depression. It is estimated that the prescription of these drugs is linked to 1,800 deaths a year in...

Alternative Titles

Full title

The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_89acb00832294f2f83c2f0f33e283964

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_89acb00832294f2f83c2f0f33e283964

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-024-12481-6

How to access this item